This site is intended for Healthcare professionals only.

Zydus gets USFDA nod for Arsenic Trioxide Injection


Zydus gets USFDA nod for Arsenic Trioxide Injection

New Delhi: Zydus Cadila has received the final approval from the USFDA to market Arsenic Trioxide Injection, 10 mg/10 mL (1 mg/mL) single-dose vial (US RLD – TRISENOX®). It will be manufactured at Alidac Pharmaceuticals Ltd., the company’s wholly-owned subsidiary located at SEZ, Ahmedabad.

Arsenic Trioxide is used to treat a type of leukaemia (acute promyelocytic leukemia-APL) when other types of treatment (e.g., chemotherapy) have not worked well or no longer work.

The group now has 228 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Read Also: Zydus Cadila gets USFDA nod for Anti-Fungal Ointment



Source: self
0 comment(s) on Zydus gets USFDA nod for Arsenic Trioxide Injection

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted